Gemina Laboratories Ltd.

GLABF · OTC
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Operating Activities
Net Income-$299-$761-$1,421-$859
Dep. & Amort.$2$29$30$30
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$13$271$61
Change in WC$280$668$1,075$542
Other Non-Cash-$5$82$9$51
Operating Cash Flow-$21$31-$36-$176
Investing Activities
PP&E Inv.$0$0$18$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$18$0
Financing Activities
Debt Repay.$0-$10-$31$19
Stock Issued-$10$0$0$0
Stock Repurch.$0$0$0-$2
Dividends Paid$0$0$0$0
Other Fin. Act.$10-$7$8-$6
Financing Cash Flow$0-$17-$24$11
Forex Effect$10$0$0$0
Net Chg. in Cash-$11$14-$41-$165
Supplemental Information
Beg. Cash$11$1$42$207
End Cash-$0$15$1$42
Free Cash Flow-$21$31-$36-$176